9
HERRERA ET AL .
TABLE 1
(Continued)
Scientific society/organization
Delegate(s)
DarkoBo ˇ zi c
EFP — Executive Committee
EFP — Executive Committee
Monique Danser
EFP — Executive Committee
Spyros Vassilopoulos
EFP — Executive Committee
Nicola West
European Society of Endodontology
Lise-Lotte Kirkevang
Other organizations Council of European Dentists
PauloMelo
IevaTamo ˇ si unait ė
European Dental Students' Association
Platform for Better Oral Health in Europe
Kenneth Eaton
People with dental implants and, therefore, at risk of developing peri-implant diseases. People with peri-implant mucositis. People with peri-implantitis. People with peri-implant mucositis, following successful peri- implant treatment. People with peri-implantitis, following successful peri-implant treatment.
Workshop Committee. This guideline development process was steered by an Organizing Committee and a methodology consultant designated by the EFP. All members of the Organizing Committee par- ticipated in the EFP Workshop Committee. To ensure adequate stakeholder involvement, the EFP established a guideline panel involving dental professionals representing national periodontal societies within the EFP, together with experts in Pros- thodontics, Implant Dentistry and Oral Surgery (Table 1). These dele- gates were nominated and selected by the Organizing Committee and participated in the guideline development process with voting rights in the consensus conference. For the guideline development process, delegates were assigned to four WGs that were chaired by selected members of the Organizing Committee and guided by the methodol- ogy consultant. This panel was supported by key stakeholders from European scientific societies with a strong professional interest in periodontal care and from European organizations representing key groups within the dental profession (Table 2), and key experts from non-EFP member regions, such as North America and Australia. In addition, the EFP engaged an independent guideline methodol- ogist to advise the panel and facilitate the consensus process (Prof. Dr. med. Ina Kopp [I.K.]). The guideline methodologist had no voting rights. The EFP and the guideline panel attempted to involve patient forums/organizations but were unable to identify any groups focused on periodontal diseases at a pan-European level. In future updates, efforts will be undertaken to include the perspectives of citizens/ patients (Brocklehurst et al., 2018). National societies will be encour- aged to involve patient groups within individual countries as key stakeholders for the Adaptation, Adoption , De Novo Development — ‘ ADOLOPMENT ’ of this CPG (Schunemann et al., 2017).
2.4
Exceptions from the guideline
|
This guideline does not consider in detail the health/economic cost – benefit ratio of the proposed therapies, since (i) the target users and patient populations include people in different countries with diverse, not readily comparable healthcare systems, and (ii) there is a paucity of sound scientific data available addressing this issue. This guideline does not consider the management of other peri- implant tissue conditions, such as hard- and soft tissue deficiencies around dental implants (Hammerle & Tarnow, 2018), unusual peri- implant problems (such as peri-implant peripheral giant-cell granuloma, pyogenic granuloma, squamous cell carcinoma, metastatic carcinomas and malignant melanoma) or implant fractures, that may mimic or share certain clinical features with biofilm-associated peri- implant conditions (Renvert et al., 2018).
3
METHODOLOGY
|
3.1
General framework
|
This guideline was developed following methodological guidance pub- lished by the Standing Guideline Commission of the Association of Scien- tific Medical Societies in Germany (AWMF) (https://www.awmf.org/ leitlinien/awmf-regelwerk/awmf-guidance.html) and the Grading of Rec- ommendations Assessment, Development and Evaluation (GRADE) Working Group (WG) (https://www.gradeworkinggroup.org/). The guideline was developed under the auspices of the European Federation of Periodontology (EFP) and overseen by the EFP
3.2
Evidence synthesis
|
3.2.1 | Systematic search and critical appraisal of guidelines
To assess and utilize existing guidelines during the development of the present guideline, we performed electronic searches in a range of
Made with FlippingBook Annual report